Veravas

Veravas Develops Proprietary Sample Pre-treatment Products and New Diagnostic TestsVeravas develops proprietary sample pre-treatment products and new diagnostic tests, providing high-value solutions for laboratories to accurately diagnose some of the world's most devastating diseases. The company has also established new strategic partnerships to bring other diagnostic applications to the clinical in vitro diagnostic (IVD) market. Its proprietary sample preparation technology uses nano-magnetic beads that can be added to a patient’s test sample. This core technology is capable of capturing specific substances for removal, as well as concentrating and quantifying these factors to improve the measurement of complex biomarkers. The company is rapidly advancing the commercialization of its patented sample preparation and sample interference products, while also developing new diagnostic tests for the IVD market. Veravas is currently leveraging its proprietary nanoparticle technology and VeraPrep™ reagents to develop IVD testing solutions for the COVID-19 market.